Senior Leadership

Steve S. Sommer, MD, PhD, FACMG, Founder and President


  • Over 25 years clinical, research and management
  • Developed >30 methods and reagents; patents
  • City of Hope/Mayo Clinic:  Directed: research Dept of Molecular Genetics & clinical Dept of Molecular Sequence Diagnosis
  • Board Certified: Clinical and Clinical Molecular Geneticist
  • Over 300 scientific publications

One of the fathers of nascent industry

  • 1st DNA Sequencing – Sanger (1976)
  • 1st genome amplification- Mullis (1983)
  • 1st direct sequence based medical mutation analysis - Sommer: 1986

  • First clear direct sequence enabled gene challenging that erroneous notion that lousy parenting gave children autism - Sommer (with 2 other labs performing family analysis) (2003) 
  • NextGen sequencing - Rothberg (2004)
  • Mutation Shower: 4th basic mechanism of mutagenesis & “Cancer in an Instant” -Sommer (2006)
  • First Genostics focused company - Sommer (2008)
  • First Genostics integrated with pMED company –
    Sommer (2010)

Rudy O'Murray, CEO

  • National Health Lab’s Regional Director for a 5 state area (became Labcore)
  • Quest Diagnostics’ VP of Operations for 16 years (California)
  • Founder and COO of TLC (The Lab Choice) (California)
  • Director of Operations for LabCorp (California)
  • Director of Operations, Western Division for Sonic Healthcare USA

QinQin Zha, MD, PhD, Director of Clinical Mutation Analysis

  • Ph.D., biochemistry and molecular biology, Peking University (the Yale of china).
  • Post-doctoral, Dept. of Neurobiology at the University of California, Irvine and Dept. of Biomedicine, East Tennessee University.
  • Baxter, rich research experience in protein trafficking, neurobiochemistry, cell signaling transduction, assay validation and drug development, a sound foundation for transition to molecular diagnostics and personalized medicine.

Zhenjiang Lan, Lead Bioinformaticist

  • MS, Sichuan University.
  • Bioinformatician/research assistant, Univ. of Houston and Rice University
  • Medomcs:   database management, bioinformatic programming and data analysis, databases design, pipeline development and LIS development

Adam Rin, PhD: Chair, Advisory Board

  • Provides business advisory services to MEDomics
  • Provides marketing consultancy services
  • Leads information systems and bioinformatics solutions for MEDomics


  • Over 40 years as manager/executive, starting with software system design, then VP in high-tech firms, to division president, Gartner Inc. [NYSE:IT], leading IT Research & Advisory firm with $1 billion revenue
  • Partner in VC firm focusing on IT and web investments;
  • Proactively served on over 10 boards of directors
  • Serial entrepreneur: Grown businesses where web technologies were a key element of product delivery and customer service